OGN vs TAYD · P/E 3.4, rev $3.02B vs P/E 17, rev $41.6M
Organon & Co (OGN) versus Taylor Devices Inc (TAYD) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Taylor Devices Inc (TAYD) is a specialty industrial machinery company listed on US.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported TAYD revenue for 2026-05-31 was $41.6M. Net income was $8.6M. Revenue was down 10.0% from 2025-05-31 to 2026-05-31. TAYD currently screens at market cap $170.7M and trailing P/E 16.8.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. TAYD currently screens at market cap $170.7M and trailing P/E 16.8.
Not investment advice. Open the OGN and TAYD stock pages for the full models.
Not investment advice.